H19 and breast angiosarcoma: Additionally, emerging evidence suggests that certain traditional Chinese medicines exert anti-fibrotic effects by targeting H19, further highlighting its potential as a therapeutic target.<h4>Conclusion</h4>This review comprehensively and systematically delineates the key regulatory network of H19 in BA, highlighting its translational potential as a novel therapeutic target and laying a theoretical foundation for future mechanistic exploration and clinical translation.